Nipro Corp
TSE:8086

Watchlist Manager
Nipro Corp Logo
Nipro Corp
TSE:8086
Watchlist
Price: 1 498.5 JPY 1.15% Market Closed
Market Cap: 244.4B JPY
Have any thoughts about
Nipro Corp?
Write Note

Net Margin
Nipro Corp

0.2%
Current
2%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.2%
=
Net Income
1.3B
/
Revenue
612.9B

Net Margin Across Competitors

Country JP
Market Cap 244.4B JPY
Net Margin
0%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 38.2B CHF
Net Margin
12%
Country DK
Market Cap 177.1B DKK
Net Margin
19%
Country US
Market Cap 16.3B USD
Net Margin
11%
Country KR
Market Cap 10.3T KRW
Net Margin
-358%
Country CN
Market Cap 51B CNY
Net Margin
42%
Country US
Market Cap 6.7B USD
Net Margin
29%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country UK
Market Cap 4.6B GBP
Net Margin
7%
Country US
Market Cap 5.6B USD
Net Margin
9%
No Stocks Found

Nipro Corp
Glance View

Market Cap
244.4B JPY
Industry
Health Care

Nipro Corporation, a prominent player in the medical industry, began as a humble glass-tubing business in the heart of Japan in 1954. Over the decades, it metamorphosed into a sprawling conglomerate with a nuanced focus on healthcare. Today, Nipro is intricately woven into the fabric of the medical supply chain. Its products range from dialysis equipment to diabetes care and even medical glass products, evidencing a broad spectrum of specialties. This diversification is not simply an expansion but a strategic integration that enables the company to leverage its expertise across related domains, ensuring resilience in the ever-evolving healthcare market. The engine powering Nipro’s business model lies in its vertical integration and global footprint. By manufacturing an array of products internally, from raw materials like glass and plastics to final medical devices, Nipro maintains stringent quality control and cost efficiencies. Beyond Japan, the company has established a significant presence in over 50 countries, tapping into diverse markets with its extensive portfolio. Strategic partnerships and mergers further bolster its global expansiveness, enhancing its distribution networks. The seamless intersection of innovation, quality, and market reach solidifies Nipro's stature as a leading entity in healthcare solutions, driving its sustained financial performance.

Intrinsic Value
2 573.93 JPY
Undervaluation 42%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.2%
=
Net Income
1.3B
/
Revenue
612.9B
What is the Net Margin of Nipro Corp?

Based on Nipro Corp's most recent financial statements, the company has Net Margin of 0.2%.